147 related articles for article (PubMed ID: 17587849)
1. Etanercept in the treatment of vitiligo.
Rigopoulos D; Gregoriou S; Larios G; Moustou E; Belayeva-Karatza E; Kalogeromitros D
Dermatology; 2007; 215(1):84-5. PubMed ID: 17587849
[No Abstract] [Full Text] [Related]
2. Etanercept treatment in a hemodialysis patient with severe cyclosporine-resistant psoriasis and hepatitis C virus infection.
Cassano N; Vena GA
Int J Dermatol; 2008 Sep; 47(9):980-1. PubMed ID: 18937672
[No Abstract] [Full Text] [Related]
3. Is once a week enough?
Bawa S; Hall J; Edmonds S; Webley M
J Rheumatol; 2007 Aug; 34(8):1783; author reply 1783-4. PubMed ID: 17902205
[No Abstract] [Full Text] [Related]
4. Recalcitrant hand pompholyx: variable response to etanercept.
Ogden S; Clayton TH; Goodfield MJ
Clin Exp Dermatol; 2006 Jan; 31(1):145-6. PubMed ID: 16309517
[No Abstract] [Full Text] [Related]
5. Effect of etanercept on insulin secretion and insulin sensitivity in a randomized trial with psoriatic patients at risk for developing type 2 diabetes mellitus.
Martínez-Abundis E; Reynoso-von Drateln C; Hernández-Salazar E; González-Ortiz M
Arch Dermatol Res; 2007 Nov; 299(9):461-5. PubMed ID: 17726611
[TBL] [Abstract][Full Text] [Related]
6. Etanercept in the treatment of macrophage activation syndrome.
Prahalad S; Bove KE; Dickens D; Lovell DJ; Grom AA
J Rheumatol; 2001 Sep; 28(9):2120-4. PubMed ID: 11550985
[TBL] [Abstract][Full Text] [Related]
7. Pilot study of etanercept in patients with relapsed cutaneous T-cell lymphomas.
Tsimberidou AM; Giles FJ; Duvic M; Kurzrock R
J Am Acad Dermatol; 2004 Aug; 51(2):200-4. PubMed ID: 15280837
[TBL] [Abstract][Full Text] [Related]
8. Etanercept in a 7-year-old boy with severe and recalcitrant psoriasis.
Safa G; Loppin M; Bousser AM; Barbarot S
J Am Acad Dermatol; 2007 Feb; 56(2 Suppl):S19-20. PubMed ID: 17097376
[No Abstract] [Full Text] [Related]
9. Three significant cases of neutropenia with etanercept.
Wenham C; Gadsby K; Deighton C
Rheumatology (Oxford); 2008 Mar; 47(3):376-7. PubMed ID: 18180249
[No Abstract] [Full Text] [Related]
10. Effectiveness of a once weekly double dose of etanercept in patients with juvenile idiopathic arthritis: a clinical study.
Prince FH; Twilt M; Jansen-Wijngaarden NC; van Suijlekom-Smit LW
Ann Rheum Dis; 2007 May; 66(5):704-5. PubMed ID: 17324973
[No Abstract] [Full Text] [Related]
11. Severe acne successfully treated with etanercept.
Campione E; Mazzotta AM; Bianchi L; Chimenti S
Acta Derm Venereol; 2006; 86(3):256-7. PubMed ID: 16710590
[No Abstract] [Full Text] [Related]
12. Tumor necrosis factor-α in vitiligo: direct correlation between tissue levels and clinical parameters.
Kim NH; Torchia D; Rouhani P; Roberts B; Romanelli P
Cutan Ocul Toxicol; 2011 Sep; 30(3):225-7. PubMed ID: 21388239
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of tarcrolimus cream 0.1% in the treatment of vitiligo.
Xu AE; Zhang DM; Wei XD; Huang B; Lu LJ
Int J Dermatol; 2009 Jan; 48(1):86-90. PubMed ID: 19126059
[TBL] [Abstract][Full Text] [Related]
14. High-dose initiation of etanercept in psoriatic arthritis and plaque psoriasis: efficacy, safety and impact on patients' quality of life.
De Felice C; Mazzotta A; Esposito M; Bianchi L; Chimenti S
J Dermatolog Treat; 2006; 17(6):355-8. PubMed ID: 17853309
[TBL] [Abstract][Full Text] [Related]
15. Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension.
van de Kerkhof PC; Segaert S; Lahfa M; Luger TA; Karolyi Z; Kaszuba A; Leigheb G; Camacho FM; Forsea D; Zang C; Boussuge MP; Paolozzi L; Wajdula J
Br J Dermatol; 2008 Nov; 159(5):1177-85. PubMed ID: 18673365
[TBL] [Abstract][Full Text] [Related]
16. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
Gisondi P; Del Giglio M; Cotena C; Girolomoni G
Br J Dermatol; 2008 Jun; 158(6):1345-9. PubMed ID: 18410408
[TBL] [Abstract][Full Text] [Related]
17. Long-term control with etanercept (Enbrel) of a severe acrodermatitis continua of Hallopeau refractory to infliximab (Remicade).
Thielen AM; Barde C; Marazza G; Saurat JH
Dermatology; 2008; 217(2):137-9. PubMed ID: 18503258
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of etanercept and adalimumab with and without a loading dose for psoriasis: A systematic review.
Gilbert KE; Manalo IF; Wu JJ
J Am Acad Dermatol; 2015 Aug; 73(2):329-31. PubMed ID: 26183982
[No Abstract] [Full Text] [Related]
19. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.
Driessen RJ; Boezeman JB; van de Kerkhof PC; de Jong EM
Br J Dermatol; 2009 Mar; 160(3):670-5. PubMed ID: 19210502
[TBL] [Abstract][Full Text] [Related]
20. Etanercept and the treatment of multicentric reticulohistiocytosis.
Lovelace K; Loyd A; Adelson D; Crowson N; Taylor JR; Cornelison R
Arch Dermatol; 2005 Sep; 141(9):1167-8. PubMed ID: 16172321
[No Abstract] [Full Text] [Related]
[Next] [New Search]
